We don’t always get what we want. But that shouldn’t stop us from wishing, right?
So we reached out to executives around healthcare to get their wish lists for the industry as we enter the next decade.
From taking on regulatory requirements to better harnessing telehealth, here’s what they had to say.
Policymakers prioritizing legislation to fight superbugs
“With impeachment looming and the 2020 presidential election set to take center stage, it will be hard for antimicrobial resistance to break through the noise in the media. I hope to read that Washington lawmakers put partisan politics aside and prioritize policies that will save millions of lives. When it comes to legislation to fight superbugs, we need a package of incentives—including Medicare reimbursement reforms, pull incentives to reward FDA approval of novel antimicrobials and push incentives to support research and development programs.
The Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act is a good first step. The DISARM Act would increase Medicare funding to hospitals that appropriately use innovative antibiotics. The Centers for Medicare & Medicaid Services recently finalized a rule that would allow hospitals to receive additional Medicare reimbursement for prescribing newer antibiotics to treat drug-resistant infections. I hope to see more policy solutions that build on the DISARM Act to incentivize drug companies to fund antibiotic research.”
— Greg Frank, director of Working to Fight AMR
More from FierceHealthcare here.